Is early-stage investing dead? Not by a long shot in the US. The US market for early-stage investing is on the rise - good news whether you're seeking or investing money.
The competition to lure biotech investors and know-how is heating up in US states - and so are the legal battles between over fair and unfair incentives.
Tectonic shifts in the patent landscape could follow on from high-profile lawsuits challenging what can be protected by a patent and how patents are enforced that are due to be heard by the US Supreme Court this month.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and the fortnightly R&D Express, tracking reforms and investments in central and eastern Europe.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.